
Postherpetic Neuralgia (PHN) Global Market Report 2025
Description
Postherpetic Neuralgia (PHN) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on postherpetic neuralgia (phn) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for postherpetic neuralgia (phn) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postherpetic neuralgia (phn) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Patches; Drugs; Opioids
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End Users: Hospitals; Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Patches: Transdermal Drug Delivery Patches; Nicotine Patches; Hormone Replacement Therapy Patches; Analgesic Patches; Orthopedic Support Patches
2) By Drugs: Prescription Drugs; Over-The-Counter (OTC) Drugs; Generic Drugs; Branded Drugs; Biologic Drugs
3) By Opioids: Natural Opioids; Semi-Synthetic Opioids; Synthetic Opioids; Opioid Analgesics; Opioid Antagonists
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Novartis AG; GlaxoSmithKline plc; Teva Pharmaceutical Industries Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on postherpetic neuralgia (phn) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for postherpetic neuralgia (phn) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postherpetic neuralgia (phn) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Patches; Drugs; Opioids
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End Users: Hospitals; Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Patches: Transdermal Drug Delivery Patches; Nicotine Patches; Hormone Replacement Therapy Patches; Analgesic Patches; Orthopedic Support Patches
2) By Drugs: Prescription Drugs; Over-The-Counter (OTC) Drugs; Generic Drugs; Branded Drugs; Biologic Drugs
3) By Opioids: Natural Opioids; Semi-Synthetic Opioids; Synthetic Opioids; Opioid Analgesics; Opioid Antagonists
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Novartis AG; GlaxoSmithKline plc; Teva Pharmaceutical Industries Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Postherpetic Neuralgia (PHN) Market Characteristics
- 3. Postherpetic Neuralgia (PHN) Market Trends And Strategies
- 4. Postherpetic Neuralgia (PHN) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 5. Global Postherpetic Neuralgia (PHN) Growth Analysis And Strategic Analysis Framework
- 5.1. Global Postherpetic Neuralgia (PHN) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Postherpetic Neuralgia (PHN) Market Growth Rate Analysis
- 5.4. Global Postherpetic Neuralgia (PHN) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Postherpetic Neuralgia (PHN) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Postherpetic Neuralgia (PHN) Total Addressable Market (TAM)
- 6. Postherpetic Neuralgia (PHN) Market Segmentation
- 6.1. Global Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Patches
- Drugs
- Opioids
- 6.2. Global Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.3. Global Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Other End Users
- 6.4. Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Transdermal Drug Delivery Patches
- Nicotine Patches
- Hormone Replacement Therapy Patches
- Analgesic Patches
- 6.5. Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prescription Drugs
- Over-The-Counter (OTC) Drugs
- Generic Drugs
- Branded Drugs
- Biologic Drugs
- 6.6. Global Postherpetic Neuralgia (PHN) Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Natural Opioids
- Semi-Synthetic Opioids
- Synthetic Opioids
- Opioid Analgesics
- Opioid Antagonists
- 7. Postherpetic Neuralgia (PHN) Market Regional And Country Analysis
- 7.1. Global Postherpetic Neuralgia (PHN) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Postherpetic Neuralgia (PHN) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Postherpetic Neuralgia (PHN) Market
- 8.1. Asia-Pacific Postherpetic Neuralgia (PHN) Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Postherpetic Neuralgia (PHN) Market
- 9.1. China Postherpetic Neuralgia (PHN) Market Overview
- 9.2. China Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Postherpetic Neuralgia (PHN) Market
- 10.1. India Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Postherpetic Neuralgia (PHN) Market
- 11.1. Japan Postherpetic Neuralgia (PHN) Market Overview
- 11.2. Japan Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Postherpetic Neuralgia (PHN) Market
- 12.1. Australia Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Postherpetic Neuralgia (PHN) Market
- 13.1. Indonesia Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Postherpetic Neuralgia (PHN) Market
- 14.1. South Korea Postherpetic Neuralgia (PHN) Market Overview
- 14.2. South Korea Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Postherpetic Neuralgia (PHN) Market
- 15.1. Western Europe Postherpetic Neuralgia (PHN) Market Overview
- 15.2. Western Europe Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Postherpetic Neuralgia (PHN) Market
- 16.1. UK Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Postherpetic Neuralgia (PHN) Market
- 17.1. Germany Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Postherpetic Neuralgia (PHN) Market
- 18.1. France Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Postherpetic Neuralgia (PHN) Market
- 19.1. Italy Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Postherpetic Neuralgia (PHN) Market
- 20.1. Spain Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Postherpetic Neuralgia (PHN) Market
- 21.1. Eastern Europe Postherpetic Neuralgia (PHN) Market Overview
- 21.2. Eastern Europe Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Postherpetic Neuralgia (PHN) Market
- 22.1. Russia Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Postherpetic Neuralgia (PHN) Market
- 23.1. North America Postherpetic Neuralgia (PHN) Market Overview
- 23.2. North America Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Postherpetic Neuralgia (PHN) Market
- 24.1. USA Postherpetic Neuralgia (PHN) Market Overview
- 24.2. USA Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Postherpetic Neuralgia (PHN) Market
- 25.1. Canada Postherpetic Neuralgia (PHN) Market Overview
- 25.2. Canada Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Postherpetic Neuralgia (PHN) Market
- 26.1. South America Postherpetic Neuralgia (PHN) Market Overview
- 26.2. South America Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Postherpetic Neuralgia (PHN) Market
- 27.1. Brazil Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Postherpetic Neuralgia (PHN) Market
- 28.1. Middle East Postherpetic Neuralgia (PHN) Market Overview
- 28.2. Middle East Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Postherpetic Neuralgia (PHN) Market
- 29.1. Africa Postherpetic Neuralgia (PHN) Market Overview
- 29.2. Africa Postherpetic Neuralgia (PHN) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Postherpetic Neuralgia (PHN) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Postherpetic Neuralgia (PHN) Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Postherpetic Neuralgia (PHN) Market Competitive Landscape And Company Profiles
- 30.1. Postherpetic Neuralgia (PHN) Market Competitive Landscape
- 30.2. Postherpetic Neuralgia (PHN) Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 31. Postherpetic Neuralgia (PHN) Market Other Major And Innovative Companies
- 31.1. Astellas Pharma Inc.
- 31.2. Daiichi Sankyo Company Limited
- 31.3. Sun Pharmaceutical Industries Limited
- 31.4. Mylan N.V.
- 31.5. Mallinckrodt plc
- 31.6. Merz Therapeutics GmbH
- 31.7. Acorda Therapeutics Inc.
- 31.8. Scilex Holding Company
- 31.9. Elorac Inc.
- 31.10. Lexicon Pharmaceuticals Inc.
- 31.11. Oxford Cannabinoid Technologies Holdings plc
- 31.12. Teikoku Pharma USA Inc.
- 31.13. Acasti Pharma Inc.
- 31.14. Flexion Therapeutics Inc.
- 31.15. Haisco Pharmaceutical Group Co. Ltd.
- 32. Global Postherpetic Neuralgia (PHN) Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Postherpetic Neuralgia (PHN) Market
- 34. Recent Developments In The Postherpetic Neuralgia (PHN) Market
- 35. Postherpetic Neuralgia (PHN) Market High Potential Countries, Segments and Strategies
- 35.1 Postherpetic Neuralgia (PHN) Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Postherpetic Neuralgia (PHN) Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Postherpetic Neuralgia (PHN) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.